“Medication-related reactions account for up to 106,000 deaths in the United States annually,” stated Yisrael Safeek, MD, MBA, CEO and Chairman, The SafeCare Group. “In a review from 2007, adverse drug reactions were found to occur in 6.1 percent of all hospitalizations. Of these, 46 percent were preventable. The national cost of preventable in-hospital events alone has been estimated to be more than $US 2 billion annually.”

SafeCare AI software is able to extract and process valuable insight from EMR data in real-time, close to the data source, to transform it into knowledge to support instantaneous decision-making while improving medication safety.

Leveraging machine learning and deep-learning capabilities, SafeCare AI Suite fosters a new generation of AI applications, which are able to sense, reason, act and adapt, to address a range of healthcare challenges in areas such readmissions, medical errors, infections, cost, and outpatient utilization.

SafeCare AI Suite can be purchased as a standalone software platform or together with other software applications that can help hospital rankings.

About The SafeCare Group®
The SafeCare Group® was founded in 2010 and its motto is “Innovating, Disrupting, Transforming” healthcare. Since 2016, The SafeCare Group invested heavily into Artificial Intelligence (AI) software known as SafeCare AI to realize game-changing clinical, operational, and financial opportunities for hospitals. Since 2014, SafeCareSoft® SaaS solutions enable hospitals to take advantage of disruptive healthcare software known as Softwaring Healthcare Excellence® that optimize hospital ratings and regulatory accreditation. Since 2013, The SafeCare Group has provided the 100 SafeCare Hospitals® rankings. For more information about The SafeCare Group, visit www.safecaregroup.com